Virginia Commonwealth University

VCU Massey Cancer Center

Massey offers microsurgical breast reconstruction

Santosh Kale

Santosh Kale, MD, plastic surgeon in the Division of Plastic and Reconstructive Surgery at VCU Medical Center and VCU Massey Cancer Center, is one of a few plastic surgeons in the Richmond area to offer microsurgical breast reconstruction. Because of the high level of skill and specialized equipment required to perform microsurgery, this form of breast reconstruction is typically only offered at specialized medical centers such as Massey.

Continue reading →

Shaping the minds of future cancer researchers

Ross B. Mikkelsen, Ph.D.

Cancer researcher Ross B. Mikkelsen, Ph.D., member of the Radiation Biology and Oncology research program at VCU Massey Cancer Center tells his students, “researchers aren’t stupid because we make stupid mistakes, but because we don’t know what’s on the other side of an experiment. On the other hand, when you do find out what’s on the other side, you get a high that you can’t beat.”

Continue reading →

Top 5 stories from 2013

Top 5 blog posts

2013 brought on some great new research from Massey. Here are the top five stories from the past year: 1. Targeted viral therapy destroys breast cancer stem cells in preclinical experiments 2. Drug combination therapy causes cancer cells to "eat themselves" 3. From head to toe: how to perform a skin self-exam 4. Researchers look to mathematics, nature...

Continue reading →

Six Massey physicians earn 2013 Best Bedside Manner recognition

Our Health Richmond Bedside Manner

In the December 2013 issue of Our Health Richmond magazine, six Massey physicians were recognized for their kindness, empathy and attentiveness when working with patients. These inaugural Best Bedside Manner Awards seek to recognize professionals who incorporate compassionate care into their practice.

Continue reading →

Scientists uncover new target for brain cancer treatment

Keggleman Fisher Das

A new study is giving researchers hope that novel targeted therapies can be developed for glioblastoma multiforme (GBM), the most common and most aggressive form of brain cancer, after demonstrating for the first time that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) is a driving force behind the disease’s aggressive and invasive nature.

Continue reading →